Andrew is an internationally renowned epidemiologist. He started his career at University of Oxford after studying there for a DPhil (Statistics) and has held a wide range of roles across both academia and industry applying epidemiological methods to advance the understanding of human disease. Andrew was most recently Vice President Data Strategy at GSK before joining as our CEO in April 2020.